Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Norman Albert Lüchinger"'
Autor:
Emre Yengel, Benjamin Hartmeier, Henry J. Snaith, Joel Troughton, Hendrik Faber, Thomas D. Anthopoulos, Leonidas Tsetseris, Akmaral Seitkhan, Norman Albert Lüchinger, Xin Song, Iain McCulloch, Yen-Hung Lin, Marek Oszajca, Nicola Gasparini, Stefaan De Wolf, Derya Baran, Michael Rossier, Jan Kosco, Furkan Halis Isikgor, Tong Liu, Marios Neophytou
Publikováno v:
Energy & Environmental Science. 13:268-276
Optoelectronic devices typically require low-resistance ohmic contacts between the optical active layers and metal electrodes. Failure to make such a contact often results in a Schottky barrier which inhibits charge extraction and, in turn, reduces d
Autor:
Michael Rossier, Regan G. Wilks, Karen Forberich, Lei Ying, Benjamin Hartmeier, Yuanyuan Cao, Xiaoyan Du, Yakun He, Chao Liu, Yicheng Zhao, Jinghua Guo, Marcus Bär, Marek Oszajca, Alina Hauser, Thomas Heumüller, Ning Li, Julien Bachmann, Jonas Wortmann, Gebhard J. Matt, Christoph J. Brabec, Kaiqi Nie, Ening Gu, Norman Albert Lüchinger, Roberto Félix, Yi-Sheng Liu
Publikováno v:
Nano energy 89, 106373-(2021). doi:10.1016/j.nanoen.2021.106373
Simultaneously enhancing device performance and longevity, as well as balancing the requirements on cost, scalability, and simplification of processing, is the goal of interface engineering of organic solar cells (OSCs). In our work, we strategically
Autor:
Kai Oliver Brinkmann, Tim Becker, Lukas Hoffmann, Yiwang Chen, Selina Olthof, Neda Pourdavoud, Norman Albert Lüchinger, Tobias Gahlmann, Baochang Cheng, Ralf Heiderhoff, Marek Oszajca, Detlef Rogalla, Jie Zhao, Thomas Riedl, Klaus Meerholz, Ting Hu
Publikováno v:
Organic, Hybrid, and Perovskite Photovoltaics XVIII.
Perovskite solar cells (PSCs) suffer from decomposition of the active material in the presence of moisture or heat. In addition, the corrosion of metal electrodes due to halide species needs to be overcome.[1,2] Here, we introduce ALD-grown tin oxide
Publikováno v:
Biotechnology and Bioengineering. 102:1197-1208
Adenoviral, adeno-associated viral, and retroviral particles are chosen as gene delivery shuttles in more than 50% of all gene therapy clinical trials. Bulk availability of clinical-grade viral particles and their efficiency to transduce the therapeu